MEDICAMENT DESTINE A INHIBER LA DIFFERENCIATION DES CELLULES ADIPEUSES ET LA RESISTANCE A L'INSULINE

• 收藏
• 分享

专利权人:

TSINGHUA UNIVERSITY;BEIJING PROTGEN LTD.

发明人:

LUO, YONGZHANG,WANG, HUI,LI, HUI,LU, XINAN,FU, YAN,ZHAN, SHUNLI,ZHOU, DAIFU

申请号：

CA3003760

公开号：

CA3003760A1

申请日:

2015.11.03

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

Provided in the present invention is a use of endostatin or a functional variant thereof in the preparation of a drug for treating alimentary obesity, non-alcoholic fatty liver disease, insulin resistance or glucose intolerance. In an embodiment of the invention, the functional variant can be YH-16, mES, mYH-16, m003, m007, mZ101, etc.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/